Page 103 - Read Online
P. 103

Cencioni. Neuroimmunol Neuroinflammation 2020;7:277-90  I  http://dx.doi.org/10.20517/2347-8659.2020.18                Page 281

               The PD-1/PDL-1 axis has been investigated in the peripheral blood and the infiltrating lymphocytes in
               glands of patients with GD and compared with non-multinodular goitres as non-autoimmune controls
                                      [27]
               and healthy controls (HC) . A decrease of naïve as well as an increase of memory and effector subsets
                                                                                      [27]
               of CD4 T cells was observed in GD as compared with the healthy donors (HD) . Besides, infiltrating
               lymphocytes in the gland of GD patients were predominantly effector and memory cells. PD-1 was found
               higher in GD than HD in CD4 T cells, and it increased in effector memory T cells re-expressing CD45RA
               (TEMRA), effector and central memory subsets. PD-1 expression increased in infiltrating CD4 and CD8 T
               cells in infiltrating lymphocytes with predominance on effector and memory subsets. The expression of
               PDL-1 but not  programmed death ligand 2 (PDL-2) was observed in epithelial thyroid follicular cells in
               the thyroid tissue from GD patients but not in non-multinodular goitres patients .
                                                                                   [27]
               Rheumatoid arthritis (RA) is a chronic progressive inflammatory disorder characterised by damage of
               articular cartilage and joint destruction [28-31] . Environmental, genetic, infectious and hormonal factors can
               contribute to the pathogenesis of the disease [32,33] . The overproduction of TNFa generates inflammation
                                                                         [34]
               and damages the joints. The interaction of B and T lymphocytes  with synovial-like fibroblasts and
               macrophages causes the overproduction of TNFa that induces the production of several inflammatory
               cytokines, such as interleukin-6 (IL-6) [35,36] . Several animal and clinical studies revealed the presence of
               CD4 T cells in the perivascular cuff and infiltration of CD8 T cells into the tissue. Depletion of T cells or
               treatment of anti-cytokines that are involved in T-cell activation or promote antigen-presentation reduces
               inflammation. T helper 17 cells are the primary T cell subsets involved in inflammation and autoimmunity
                     [37]
                             -/-
               in RA . PD-1  C57BL/6 mice developed arthritis. PD-1 polymorphisms have been reported to be
               associated with RA [38,39] . Expression of PD-1 was detected in synovial T cells and macrophages in patients
                      [40]
               with RA . In the peripheral blood of RA patients, PD-1 was significantly decreased in CD4 T cells (P =
                                                                        [41]
               0.002) and CD8 T cells (P < 0.001) as compared with HC (P < 0.05) . DAS28 score is a measure of disease
                                                                                                       [41]
               activity in RA, and PD-1 expression was found inversely correlated with DAS28 scores in RA patients .
               Besides, CRP is an indicator of inflammation and cases with positive CRP detection had a lower proportion
                      +
                          +
                                                           [42]
               of PD-1 CD4  T cells than those with negative CRP .
               Systemic Lupus Erythematous (SLE) is an autoimmune disease generated by the production of antibodies
               against self-antigens and deposition of immune complexes in different tissues. Inflammation and
                                                        [43]
               multisystem disorders characterise the disease . The disorder affects mainly women of reproductive
               age with an incidence of 20-70 cases per 100,000 individuals [44,45] . Environmental, genetic and hormonal
               factors are relevant in the pathogenesis of the disease [46-48] . Genetic variations in the immune checkpoint
               genes such as PD-1, T-cell immunoglobulin domain, mucin domain (TIM) and CTLA-4 increase the
               susceptibility to develop the autoimmune disease as a consequence of the breakdown of immune tolerance
               to self-antigens [49,50] . Several single-nucleotide polymorphisms (SNPs) have been identified to affect PD-1
               function and to contribute to tumours and autoimmune disease [49,50] . The frequencies of PD-1 SNPs (PD1.1,
               PD1.3, PD1.5 and PD1.9) were analysed in SLE patients. The PD1.5 genotype frequency was increased in
               Iranian, Malaysian and European patients with SLE as compared with healthy donors [51-53] . The distribution
               of PD1.5 C/C, PD1.5 C/T and PD1.5 T/T genotypes versus other genotypes in patients with SLE differed
                                  [53]
               from healthy controls . In addition, there were significant differences in the PD1.5 genotypes between
               patients with renal involvement and neurological involvement and between neurological involvement and
                  [53]
               HC . The allelic analysis revealed that there was a significant association between PD1.5 allele frequency
               and SLE susceptibility .
                                  [53]
               Type I diabetes (TID) is caused by autoreactive cells that destroy the insulin-producing beta cells in the
                                          [54]
               pancreatic islet of Langerhans . PD-1 and PDL-1 protect from TID. PD-1 deficiency accelerates the
               onset and the frequency of TID in NOD (non-obese diabetic) mice and infiltration of T cells into the
               islets. PD-1 or PDL-1 but not PDL-2 blockage rapidly induces diabetes in NOD mice with an expansion
   98   99   100   101   102   103   104   105   106   107   108